

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
You can purchase shares of Pulmatrix (NASDAQ:PULM) through any online brokerage.
Other companies in Pulmatrix’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Pulmatrix to provide a consensus price target.
The stock price for Pulmatrix (NASDAQ: PULM) is $1.4 last updated October 23, 2026 at 6:58 AM EDT.
There are no upcoming dividends for Pulmatrix.
Pulmatrix does not have any upcoming earnings scheduled.
There is no upcoming split for Pulmatrix.
Pulmatrix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery...